在AAPI大学生中理解ADHD:患病率,并发症,障碍和治疗利用率
Nandini Jhawar1, Kevin M Antshel1
1Syracuse University, NY, USA.
Journal of attention disorders
|October 21, 2023
概括
亚裔美国人和太平洋岛民 (AAPI) 患有注意力缺陷/多动障碍 (ADHD) 的大学生表现出更高的损伤风险,但治疗使用率较低. 许多ADHD的AAPI学生面临重大挑战,而没有寻求必要的护理.
科学领域:
- 精神病学是一个精神病学.
- 高等教育 高等教育
- 健康差异 在健康上的差异
背景情况:
- 亚裔美国人和太平洋岛民 (AAPI) 患有注意力缺陷/多动障碍 (ADHD) 的学生可能会经历更大的大学不适应.
- 文化因素和延迟寻求治疗有助于ADHD的AAPI学生的风险.
- 这项研究是首次对AAPI大学生进行全面的ADHD调查.
研究的目的:
- 为了检查AAPI大学生中ADHD的患病率.
- 在AAPI学生中评估与ADHD相关的障碍和并发症.
- 评估在AAPI大学生人群中使用ADHD治疗的情况.
主要方法:
- 利用了美国大学健康协会-全国大学健康评估II调查的数据.
- 包括258,005名AAPI,白人,西班牙裔和黑人本科生.
- 分析了跨种族/族群的ADHD患病率,并发症,障碍和治疗使用情况.
主要成果:
- AAPI学生的ADHD患病率低于白人和黑人学生,与西班牙裔学生相比.
- 与患有ADHD的白人学生相比,患有ADHD的AAPI学生对并发症和社会/学术障碍的风险更高.
- 大约50%的ADHD的AAPI学生没有接受治疗,尽管有精神病并发症和功能障碍.
结论:
- 患有ADHD的AAPI大学生没有充分利用治疗.
- 高度的精神病并发症和功能障碍在ADHD的AAPI学生中很普遍.
- 需要有针对性的干预措施来改善ADHD治疗的准入和AAPI学生的结果.
更多相关视频
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
15.7K
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
10.4K
相关概念视频
Attention-Deficit/Hyperactivity Disorder
73
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
73
Modeling in Therapy
92
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
92
Diagnostic and Statistical Manual of Mental Disorders (DSM)
59
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
59
Conduct Disorder
37
Conduct disorder is a complex mental health diagnosis characterized by a repetitive and persistent pattern of behavior that violates societal norms, the rights of others, or age-appropriate rules. The diagnostic criteria for conduct disorder require the presence of at least three problematic behaviors within the past 12 months, with at least one occurring in the past six months. These behaviors are grouped into four categories: aggression toward people and animals; destruction of property;...
37
Autism Spectrum Disorder
104
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
104
Alzheimer's Disease: Treatment
200
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
200
